Skip to Content

ETH 383 (Carbidopa and Levodopa Extended Release 50 mg / 200 mg)

Pill with imprint ETH 383 is Orange, Elliptical / Oval and has been identified as Carbidopa and Levodopa Extended Release 50 mg / 200 mg. It is supplied by Ethex Corporation.

Carbidopa/levodopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 50 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ETH 383

Carbidopa and levodopa extended release 50 mg / 200 mg ETH 383

Carbidopa and Levodopa Extended Release

Imprint
ETH 383
Strength
50 mg / 200 mg
Color
Orange
Size
13.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Ethex Corporation
National Drug Code (NDC)
58177-0383

Get help with Imprint Code FAQs.

Related Images for "ETH 383"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.